Trials / Not Yet Recruiting
Not Yet RecruitingNCT06150222
Retrospective Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study
Retrospective Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study (Retro-COSMOS). An EMBRACE Collaborative Initiative in Recurrent and Metastatic Cervix Cancer.
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 350 (estimated)
- Sponsor
- Erasmus Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This multi centric international retrospective study aims to register patients with oligo metastatic and oligo recurrent cervical cancer. The study will register patients in planned period with an aim to analyse clinical outcomes with or without use of radiation in this setting.
Detailed description
Detailed clinical protocol can be obtained by contacting the principal investigator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Concurrent Chemoradiation, Systemic Chemotherapy other locally directed therapies (like surgery, ablation, etc.) | The aim is to include all patients with (induced) oligo metastatic and oligo recurrent settings, irrespective of whether treated with concurrent chemoradiation, systemic chemotherapy, or with other locally directed therapies (like surgery, ablation, etc.) |
Timeline
- Start date
- 2023-11-30
- Primary completion
- 2026-07-31
- Completion
- 2027-07-31
- First posted
- 2023-11-29
- Last updated
- 2023-12-01
Source: ClinicalTrials.gov record NCT06150222. Inclusion in this directory is not an endorsement.